Wall 
AZN - AstraZeneca
Annual data, 1996 to 2026, in US$ millions.
Last updated: Oct 3, 2026
Capital
Dividend
Revenue
Income
Asset
Equity
Rolling CAGR% per year, window ending each year
Other companies
Novartis
Data since 1998
Amgen
Data since 1996
Gilead Sciences
Data since 1996
Novo Nordisk
Data since 1996
Pfizer
Data since 1996
Roche
Data since 1998
Merck
Data since 1996
Vertex Pharmaceuticals
Data since 1996
Bristol-Myers Squibb
Data since 1996
Sanofi
Data since 2001
GSK plc
Data since 1996
WuXi AppTec
Data since 2014
Moderna
Data since 2016
Regeneron Pharmaceuticals
Data since 1996
AbbVie
Data since 2010
Johnson & Johnson
Data since 1996
Eli Lilly
Data since 1996
Thermo Fisher Scientific
Data since 1996
CVS Health
Data since 1996
Wells Fargo
Data since 1996
Siemens
Data since 2000
Marvell Technology
Data since 2000
SAP
Data since 1998
MediaTek
Data since 2006
RTX
Data since 1996
Kweichow Moutai
Data since 2001
Sandisk
Data since 1996
Nestlé
Data since 1998
Mitsubishi UFJ Financial
Data since 1996
SoftBank Group Corp.
Data since 2000
2026 is partial: Capital is the current value; Revenue and Income are TTM; Asset and Equity are the latest quarter reported. CAGR runs through 2026. Rolling CAGR needs positive values at both ends of the window. Dividend = yield × Capital (approximate). Orange bars mark years that fell from the prior year. Y axes are log scale, so zero or negative values are not shown.